New hope for rare lung cancer: targeted pill tepotinib faces final test

NCT ID NCT06908993

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 3 trial is testing whether the targeted drug tepotinib works better than standard treatments for people with advanced non-small cell lung cancer that has a specific genetic change (MET exon 14 mutation). About 133 patients who have already tried at least one prior treatment will be randomly assigned to receive either tepotinib pills or one of several standard chemotherapy or immunotherapy options. The main goal is to see if tepotinib delays cancer growth and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Tepotinib

What this could lead to

If successful, this trial could provide a new, more effective treatment option for people with a specific type of advanced lung cancer, potentially improving how long they live without their cancer growing and their quality of life.

What could go wrong

This is a Phase 3 trial, but it's relatively small (133 people). Tepotinib can cause side effects like swelling, nausea, and diarrhea, which may be serious in some cases. The benefit in overall survival may be hard to measure because patients in the control group can switch to tepotinib if their cancer worsens.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AP-HP Hôpital Cochin

    RECRUITING

    Paris, 75014, France

    Contact Email: •••••@•••••

  • AP-HP Hôpital Tenon

    RECRUITING

    Paris, 75970, France

    Contact Email: •••••@•••••

  • Besançon - CHU

    RECRUITING

    Besançon, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Bordeaux - CHU

    RECRUITING

    Pessac, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Bordeaux - Institut Bergonie

    RECRUITING

    Bordeaux, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Brest - CHU

    RECRUITING

    Brest, France

    Contact

    Contact

  • CH de Valence

    RECRUITING

    Valence, France

    Contact Email: •••••@•••••

  • CHD Vendée

    RECRUITING

    La Roche-sur-Yon, France

    Contact Email: •••••@•••••

    Contact

  • CHRU de Lille

    RECRUITING

    Lille, France

    Contact Email: •••••@•••••

  • CHRU de Tours

    RECRUITING

    Tours, France

    Contact Email: •••••@•••••

  • CHU Toulouse

    RECRUITING

    Toulouse, France

    Contact Email: •••••@•••••

  • Caen - CRLCC

    RECRUITING

    Caen, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Centre Antoine Lacassagne

    RECRUITING

    Nice, France

    Contact

    Contact Email: •••••@•••••

  • Centre Hospitalier Général - Pau

    RECRUITING

    Pau, 64000, France

    Contact Email: •••••@•••••

  • Centre Hospitalier Intercommunal de Créteil

    RECRUITING

    Créteil, 94000, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Léon Bérard

    RECRUITING

    Lyon, 69373, France

    Contact

  • Dijon - Centre Georges-François Leclerc

    RECRUITING

    Dijon, 21000, France

    Contact Email: •••••@•••••

  • Grenoble - CHU

    RECRUITING

    Grenoble, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Gustave Roussy

    RECRUITING

    Villejuif, France

    Contact Email: •••••@•••••

  • Institut Paoli Calmette

    RECRUITING

    Marseille, France

    Contact Email: •••••@•••••

  • Institut de Cancérologie de l'Ouest - René Gauducheau

    RECRUITING

    Saint-Herblain, 44805, France

    Contact

  • Le Mans - CHG

    RECRUITING

    Le Mans, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Marseille - APHM

    RECRUITING

    Marseille, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Montpellier - CHU

    RECRUITING

    Montpellier, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Nancy - CHU

    RECRUITING

    Vandœuvre-lès-Nancy, 54500, France

    Contact

  • Paris - APHP Bichat

    RECRUITING

    Paris, France

    Contact Email: •••••@•••••

    Contact

  • Sens - CH

    RECRUITING

    Sens, 89100, France

    Contact Email: •••••@•••••

    Contact

  • Strasbourg - NHC

    RECRUITING

    Strasbourg, 63000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Toulon - CHI

    RECRUITING

    Toulon, 83000, France

    Contact Email: •••••@•••••